These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 21166197)
1. [Study on effects of injection Salvia miltiorrhiza against ototoxicity induced by anticancer agent of cisplatin]. Liao YJ; Tang H Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 May; 20(2):140-1, 155. PubMed ID: 21166197 [No Abstract] [Full Text] [Related]
2. Protective effects of Salvia miltiorrhiza against cisplatin-induced ototoxicity in guinea pigs. Xu O; Liu Y; Li X; Yang Y; Zhang Z; Wang N; Zhang Y; Lu H Am J Otolaryngol; 2011; 32(3):228-34. PubMed ID: 20447728 [TBL] [Abstract][Full Text] [Related]
3. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750 [TBL] [Abstract][Full Text] [Related]
4. [Effect of injectio Salvia Miltiorrhiza on gentamicin ototoxicity-induced activity of nitric oxide synthase in cochlear stria vascularis of guinea pig]. Wang AM; Tang H; Shen J; Cui GY; Cui C Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 Feb; 17(1):89-92. PubMed ID: 21171455 [TBL] [Abstract][Full Text] [Related]
5. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications. Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230 [TBL] [Abstract][Full Text] [Related]
6. Tanshinones isolated from the rhizome of Salvia miltiorrhiza inhibit passive cutaneous anaphylaxis reaction in mice. Trinh HT; Chae SJ; Joh EH; Son KH; Jeon SJ; Kim DH J Ethnopharmacol; 2010 Oct; 132(1):344-8. PubMed ID: 20732401 [TBL] [Abstract][Full Text] [Related]
7. Astragalosides reduce cisplatin ototoxicity in guinea pigs. Xiong M; He Q; Wang J; Lai H ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054 [TBL] [Abstract][Full Text] [Related]
8. [iNOS and AChE expression on guinea pigs cochlea spiral ganglion induced by streptomycin and attenuation by Salvia miltiorrhiza injection]. Shi LJ; Guan J; Tang H Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):264-7. PubMed ID: 21189568 [TBL] [Abstract][Full Text] [Related]
9. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919 [TBL] [Abstract][Full Text] [Related]
10. Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity. Carleton BC; Ross CJ; Bhavsar AP; Amstutz U; Pussegoda K; Visscher H; Lee JW; Brooks B; Rassekh SR; Dubé MP; Hayden MR Clin Pharmacol Ther; 2014 Mar; 95(3):253. PubMed ID: 24193170 [No Abstract] [Full Text] [Related]
11. Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice. He J; Yin S; Wang J; Ding D; Jiang H Acta Otolaryngol; 2009 Dec; 129(12):1359-67. PubMed ID: 19922082 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity. Lanvers-Kaminsky C; Malath I; Deuster D; Ciarimboli G; Boos J; Am Zehnhoff-Dinnesen AG Clin Pharmacol Ther; 2014 Aug; 96(2):156-7. PubMed ID: 24642735 [No Abstract] [Full Text] [Related]
13. Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity". Carleton BC; Ross CJ; Bhavsar AP; Lee JW; Visscher H; Rassekh SR; Hayden MR Clin Pharmacol Ther; 2014 Aug; 96(2):158. PubMed ID: 24755913 [No Abstract] [Full Text] [Related]
14. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950 [TBL] [Abstract][Full Text] [Related]
15. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295 [TBL] [Abstract][Full Text] [Related]
16. [Protective effects and pathogenesis of complex salvin miltiorrhiza on acute mercury poisoning in rabbits]. Jing YL; Wang YL; Yin DD; Cao BH; Zhang W; Geng F; Sun N Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):341-4. PubMed ID: 21038687 [TBL] [Abstract][Full Text] [Related]
17. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Lynch ED; Gu R; Pierce C; Kil J Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563 [TBL] [Abstract][Full Text] [Related]
18. Genetics of cisplatin ototoxicity: confirming the unexplained? Boddy AV Clin Pharmacol Ther; 2013 Aug; 94(2):198-200. PubMed ID: 23872836 [TBL] [Abstract][Full Text] [Related]
19. [Determination of the allergic impurities in the parenteral injection of Chinese traditional medicines containing Salvia miltiorrhiza]. Hu CQ; Xu MZ; Ma Y; Yu FP; Li J; Wang C; Cui SH Yao Xue Xue Bao; 2008 May; 43(5):518-22. PubMed ID: 18717341 [TBL] [Abstract][Full Text] [Related]